These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
196 related items for PubMed ID: 9051288
1. The NK1 receptor and its participation in the synergistic enhancement of corneal epithelial migration by substance P and insulin-like growth factor-1. Nakamura M, Ofuji K, Chikama T, Nishida T. Br J Pharmacol; 1997 Feb; 120(4):547-52. PubMed ID: 9051288 [Abstract] [Full Text] [Related]
2. Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea. Nishida T, Nakamura M, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. J Cell Physiol; 1996 Oct; 169(1):159-66. PubMed ID: 8841432 [Abstract] [Full Text] [Related]
4. Synergistic effect of substance P with epidermal growth factor on epithelial migration in rabbit cornea. Nakamura M, Nishida T, Ofuji K, Reid TW, Mannis MJ, Murphy CJ. Exp Eye Res; 1997 Sep; 65(3):321-9. PubMed ID: 9299169 [Abstract] [Full Text] [Related]
5. Differential activation of the epithelial and smooth muscle NK1 receptors by synthetic tachykinin agonists in guinea-pig trachea. Figini M, Emanueli C, Bertrand C, Sicuteri R, Regoli D, Geppetti P. Br J Pharmacol; 1997 Jun; 121(4):773-81. PubMed ID: 9208147 [Abstract] [Full Text] [Related]
6. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study. Nsa Allogho S, Nguyen-Le XK, Gobeil F, Pheng LH, Regoli D. Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127 [Abstract] [Full Text] [Related]
7. Sensitizing effect of substance P on corneal epithelial migration induced by IGF-1, fibronectin, or interleukin-6. Yamada N, Yanai R, Inui M, Nishida T. Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):833-9. PubMed ID: 15728538 [Abstract] [Full Text] [Related]
8. NK1 receptor-mediated endothelium-dependent relaxation and contraction with different sensitivity to post-receptor signaling in pulmonary arteries. Miike T, Shirahase H, Kanda M, Kunishiro K, Kurahashi K. Vascul Pharmacol; 2009 Mar; 51(2-3):147-53. PubMed ID: 19539781 [Abstract] [Full Text] [Related]
9. Participation of p38 MAP kinase, but not p44/42 MAP kinase, in stimulation of corneal epithelial migration by substance P and IGF-1. Nakamura M, Chikama T, Nishida T. Curr Eye Res; 2005 Oct; 30(10):825-34. PubMed ID: 16251119 [Abstract] [Full Text] [Related]
10. Promotion of corneal epithelial wound healing by a tetrapeptide (SSSR) derived from IGF-1. Yamada N, Yanai R, Kawamoto K, Nagano T, Nakamura M, Inui M, Nishida T. Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3286-92. PubMed ID: 16877393 [Abstract] [Full Text] [Related]
11. Effect of neurokinins on canine prostate cell physiology. Walden PD, Marinese D, Srinivasan D, Tzoumaka E, Syyong HT, Ford AP, Bhattacharya A. Prostate; 2005 Jun 01; 63(4):358-68. PubMed ID: 15611996 [Abstract] [Full Text] [Related]
12. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide. Ciucci A, Palma C, Manzini S, Werge TM. Br J Pharmacol; 1998 Sep 01; 125(2):393-401. PubMed ID: 9786514 [Abstract] [Full Text] [Related]
13. [Neurotrophic keratopathy--studies on substance P and the clinical significance of corneal sensation]. Nishida T, Nakamura M, Konma T, Ofuji K, Nagano K, Tanaka T, Enoki M, Reid TW, Brown SM, Murphy CJ, Mannis MJ. Nippon Ganka Gakkai Zasshi; 1997 Dec 01; 101(12):948-74. PubMed ID: 9436358 [Abstract] [Full Text] [Related]
14. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct. Patacchini R, Barthó L, Maggi CA. Br J Pharmacol; 1997 Dec 01; 122(8):1633-8. PubMed ID: 9422808 [Abstract] [Full Text] [Related]
15. Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation. Ainscough SL, Barnard Z, Upton Z, Harkin DG. Exp Eye Res; 2006 Dec 01; 83(6):1505-14. PubMed ID: 17046752 [Abstract] [Full Text] [Related]
16. Neurokinin receptor modulation of respiratory activity in the rabbit. Bongianni F, Mutolo D, Cinelli E, Pantaleo T. Eur J Neurosci; 2008 Jun 01; 27(12):3233-43. PubMed ID: 18554294 [Abstract] [Full Text] [Related]
17. Comparative, general pharmacology of SDZ NKT 343, a novel, selective NK1 receptor antagonist. Walpole CS, Brown MC, James IF, Campbell EA, McIntyre P, Docherty R, Ko S, Hedley L, Ewan S, Buchheit KH, Urban LA. Br J Pharmacol; 1998 May 01; 124(1):83-92. PubMed ID: 9630347 [Abstract] [Full Text] [Related]
18. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist. Catalioto RM, Criscuoli M, Cucchi P, Giachetti A, Gianotti D, Giuliani S, Lecci A, Lippi A, Patacchini R, Quartara L, Renzetti AR, Tramontana M, Arcamone F, Maggi CA. Br J Pharmacol; 1998 Jan 01; 123(1):81-91. PubMed ID: 9484857 [Abstract] [Full Text] [Related]
19. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to MAP kinase. Jeurissen F, Kavelaars A, Korstjens M, Broeke D, Franklin RA, Gelfand EW, Heijnen CJ. J Immunol; 1994 Mar 15; 152(6):2987-94. PubMed ID: 7511635 [Abstract] [Full Text] [Related]
20. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat. Magraner J, Pinto FM, Anselmi E, Hernandez M, Perez-Afonso R, Martín JD, Advenier C, Candenas ML. Br J Pharmacol; 1998 Jan 15; 123(2):259-68. PubMed ID: 9489614 [Abstract] [Full Text] [Related] Page: [Next] [New Search]